Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2001
Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts
M N Kirstein, P J Houghton, P J Cheshire, et al.
Anti-Cancer Drugs
|
April 1, 1997
Efficacy of oral irinotecan against neuroblastoma xenografts
J Thompson, W C Zamboni, P J Cheshire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate
W R Crom, C B Pratt, A A Green, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia
W E Evans, J H Rodman, M V Relling, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 26, 2013
Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data
M O Jacus, S L Throm, D C Turner, et al.
Cancer Research
|
August 17, 2000
Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase
C L Morton, M Wierdl, L Oliver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts
W C Zamboni, P J Houghton, J Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Efficacy of systemic administration of irinotecan against neuroblastoma xenografts
J Thompson, W C Zamboni, P J Cheshire, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 23, 2017
Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas
Y T Patel, V M Daryani, P Patel, et al.
Seminars in Oncology
|
February 1, 1993
Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children
J H Rodman, M V Relling, C F Stewart, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2001
Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts
M N Kirstein, P J Houghton, P J Cheshire, et al.
Anti-Cancer Drugs
|
April 1, 1997
Efficacy of oral irinotecan against neuroblastoma xenografts
J Thompson, W C Zamboni, P J Cheshire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate
W R Crom, C B Pratt, A A Green, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia
W E Evans, J H Rodman, M V Relling, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 26, 2013
Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data
M O Jacus, S L Throm, D C Turner, et al.
Cancer Research
|
August 17, 2000
Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase
C L Morton, M Wierdl, L Oliver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts
W C Zamboni, P J Houghton, J Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Efficacy of systemic administration of irinotecan against neuroblastoma xenografts
J Thompson, W C Zamboni, P J Cheshire, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 23, 2017
Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas
Y T Patel, V M Daryani, P Patel, et al.
Seminars in Oncology
|
February 1, 1993
Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children
J H Rodman, M V Relling, C F Stewart, et al.
Page
of 10